115 related articles for article (PubMed ID: 2840788)
1. Agranulocytosis induced by aminoglutethimide.
Mathijs R; Coolen D; Hermans-Debaive C
Acta Clin Belg; 1988; 43(2):146-8. PubMed ID: 2840788
[No Abstract] [Full Text] [Related]
2. Aminoglutethimide (with hydrocortisone) induced agranulocytosis in primary breast cancer.
Vincent MD; Clink HM; Coombes RC; Smith IE; Kandler R; Powles TJ
Br Med J (Clin Res Ed); 1985 Jul; 291(6488):105-6. PubMed ID: 2990631
[No Abstract] [Full Text] [Related]
3. Pancytopenia induced by aminoglutethimide in the treatment of breast cancer.
Lawrence B; Santen RJ; Lipton A; Harvey HA; Hamilton R; Mercurio T
Cancer Treat Rep; 1978 Oct; 62(10):1581-3. PubMed ID: 213192
[TBL] [Abstract][Full Text] [Related]
4. Agranulocytosis associated with aminoglutethimide: pharmacological and marrow studies.
Harris AL; Hughes G; Barrett AJ; Abusrewil S; Dowsett M; Smith IE
Br J Cancer; 1986 Jul; 54(1):119-22. PubMed ID: 3730249
[No Abstract] [Full Text] [Related]
5. Response to aminoglutethimide after tamoxifen therapy in advanced breast cancer.
Allison RW; Furnival CM; Lee JF; Roberts SJ
Med J Aust; 1982 Jan; 1(1):44-5. PubMed ID: 6278273
[TBL] [Abstract][Full Text] [Related]
6. Aminoglutethimide induced agranulocytosis in breast cancer.
Caldwell G; Bradbury A; Toft AD
Br Med J (Clin Res Ed); 1985 Oct; 291(6500):970-1. PubMed ID: 3929986
[No Abstract] [Full Text] [Related]
7. Randomized trial of tamoxifen versus aminoglutethimide and versus combined tamoxifen and aminoglutethimide in advanced postmenopausal breast cancer.
Alonso-Muñoz MC; Ojeda-González MB; Beltran-Fabregat M; Dorca-Ribugent J; López-López L; Borrás-Balada J; Cardenal-Alemany F; Gómez-Batiste X; Fabregat-Mayol J; Viladiu-Quemada P
Oncology; 1988; 45(5):350-3. PubMed ID: 3045726
[TBL] [Abstract][Full Text] [Related]
8. Aminoglutethimide-induced myelosuppression.
van der Heijden JT; Splinter TA
Breast Cancer Res Treat; 1986; 7(3):211-2. PubMed ID: 3779118
[No Abstract] [Full Text] [Related]
9. Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer.
Lipton A; Harvey HA; Santen RJ; Boucher A; White D; Bernath A; Dixon R; Richards G; Shafik A
Cancer Res; 1982 Aug; 42(8 Suppl):3434s-3436s. PubMed ID: 7044526
[TBL] [Abstract][Full Text] [Related]
10. Oestrogen receptors and the response of metastatic breast cancer to aminoglutethimide or tamoxifen.
Holdaway IM
Aust N Z J Surg; 1981 Aug; 51(4):345-7. PubMed ID: 6944051
[TBL] [Abstract][Full Text] [Related]
11. Treatment of breast carcinoma with aminoglutethimide.
Kvinnsland S; Lønning PE; Dahl O
Acta Radiol Oncol; 1984; 23(6):421-4. PubMed ID: 6099033
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of metastatic breast cancer with aminoglutethimide after failure of tamoxifen].
Brufman G; Biran S
Harefuah; 1984 Dec; 107(12):377-99. PubMed ID: 6532917
[No Abstract] [Full Text] [Related]
13. Aminoglutethimide after tamoxifen therapy in advanced breast cancer: M. D. Anderson Hospital experience.
Buzdar AU; Powell KC; Blumenschein GR
Cancer Res; 1982 Aug; 42(8 Suppl):3448s-3450s. PubMed ID: 7083209
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen versus aminoglutethimide versus combined tamoxifen and aminoglutethimide in the treatment of advanced breast carcinoma.
Smith IE; Harris AL; Morgan M; Gazet JC; McKinna JA
Cancer Res; 1982 Aug; 42(8 Suppl):3430s-3433s. PubMed ID: 7044525
[TBL] [Abstract][Full Text] [Related]
15. Treatment of metastatic breast cancer with aminoglutethimide after progression on chemotherapy and/or hormonal therapy with tamoxifen.
Brufman G; Biran S
Eur J Surg Oncol; 1985 Mar; 11(1):27-31. PubMed ID: 2985452
[TBL] [Abstract][Full Text] [Related]
16. Combination treatment with tamoxifen and aminoglutethimide in advanced breast cancer.
Smith IE; Harris AL; Stuart-Harris R; Ford HT; Gazet JC; White H; Harmer CL; Carr L; McKinna JA; Morgan M
Br Med J (Clin Res Ed); 1983 May; 286(6378):1615-6. PubMed ID: 6405912
[No Abstract] [Full Text] [Related]
17. Aminoglutethimide as second line endocrine therapy in advanced breast cancer.
Brufman G; Biran S
Anticancer Res; 1986; 6(5):1065-8. PubMed ID: 3800315
[TBL] [Abstract][Full Text] [Related]
18. Second line hormonal therapy with aminoglutethimide in metastatic breast cancer.
Brufman G; Biran S
Acta Oncol; 1990; 29(6):717-20. PubMed ID: 2223141
[TBL] [Abstract][Full Text] [Related]
19. Treatment of advanced breast cancer with aminoglutethimide after therapy with tamoxifen.
Buzdar AU; Powell KC; Legha SS; Blumenschein GR
Cancer; 1982 Nov; 50(9):1708-12. PubMed ID: 6180820
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of tamoxifen versus tamoxifen plus aminoglutethimide as adjuvant treatment in postmenopausal breast cancer patients with hormone receptor-positive disease: Austrian breast and colorectal cancer study group trial 6.
Schmid M; Jakesz R; Samonigg H; Kubista E; Gnant M; Menzel C; Seifert M; Haider K; Taucher S; Mlineritsch B; Steindorfer P; Kwasny W; Stierer M; Tausch C; Fridrik M; Wette V; Steger G; Hausmaninger H
J Clin Oncol; 2003 Mar; 21(6):984-90. PubMed ID: 12637461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
